Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Recessive Dystrophic Epidermolysis Bullosa
Interventions
OTHER

Blood collection

"* 5 ml of blood on dry tube: Verification of the absence of auto-antibodies to type VII collagen.~* 10 ml of blood sample on heparin: Verification of the absence of circulating reactive T-Lymphocytes clones to type VII collagen~* 5 ml of Blood samples on ethylenediaminetetraacetic acid (EDTA): HLA genotyping of patient selected on the clinical and molecular criteria."

OTHER

Skin biopsies

"* A 5-mm punch skin biopsy in the groin region performed under local anaesthesic will be undertaken during visit 1.~* During the second visit, two additional 5-mm punch skin biopsies will be taken to assess stem cells proliferative capacity in 10 shortlisted patients"

Trial Locations (3)

75743 Cedex 15

Service de dermatologie Necker Hospital for sick children, Paris

75743/ Cedex 15

Inserm U781 Service de Génétique Necker Hospital for sick children, Paris

SE19RT

Guy's and ST Thomas NHS Foundation trust/Guy's Hospital, London

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT01874769 - Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB) | Biotech Hunter | Biotech Hunter